Goldman Sachs Group »

Viracta Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Viracta Therapeutics

Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 202402M4M6M0200k400k600k
Value ($)Share countHistorical VIRX position of Goldman Sachs Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.3k 27k 0.23
2022-06-30 $792k 204k 3.88
2022-03-31 $717k 151k 4.76
2021-12-31 $702k 192k 3.65
2021-09-30 $1.4M 171k 8.02
2021-03-31 $5.6M 604k 9.25